Stay updated on Lenvatinib and Pembrolizumab in HCC Clinical Trial

Sign up to get notified when there's something new on the Lenvatinib and Pembrolizumab in HCC Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Lenvatinib and Pembrolizumab in HCC Clinical Trial page

  1. Check
    3 days ago
    Change Detected
    Summary
    Replaced the location entry 'Tainan City, Taiwan, 70457' with 'Tainan, Taiwan, 70457' to standardize the city name.
    Difference
    0.0%
    Check dated 2025-11-11T02:38:37.000Z thumbnail image
  2. Check
    10 days ago
    Change Detected
    Summary
    No additions or deletions were detected in the page content shown in the screenshots. The LEAP-002 study details page remains unchanged in its core information and structure.
    Difference
    0.2%
    Check dated 2025-11-03T21:00:32.000Z thumbnail image
  3. Check
    17 days ago
    Change Detected
    Summary
    Santiago de Cali entries (760032, 760042) were replaced with Cali entries for Valle del Cauca Department (760032, 760042). The Santiago de Cali locations were removed and the new Cali locations added.
    Difference
    0.0%
    Check dated 2025-10-27T18:23:07.000Z thumbnail image
  4. Check
    39 days ago
    Change Detected
    Summary
    Version bump to v3.2.0 accompanied by a government-operating-status notice; replaces the earlier v3.1.0 tag.
    Difference
    1%
    Check dated 2025-10-06T05:23:36.000Z thumbnail image
  5. Check
    46 days ago
    Change Detected
    Summary
    Page metadata and versioning/update timestamps have been refreshed (new date ranges, last update flag, and revision v3.1.0), replacing older values (last update, older date ranges, and revision v3.0.2). If you need deeper content changes, they are not evident from the additions/deletions provided.
    Difference
    0.7%
    Check dated 2025-09-29T03:01:43.000Z thumbnail image
  6. Check
    60 days ago
    Change Detected
    Summary
    Version bumped from v3.0.1 to v3.0.2, with the 'Back to Top' element removed. No other substantive changes to core content, pricing, stock, or time slots.
    Difference
    0.1%
    Check dated 2025-09-14T18:54:24.000Z thumbnail image

Stay in the know with updates to Lenvatinib and Pembrolizumab in HCC Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Lenvatinib and Pembrolizumab in HCC Clinical Trial page.